Stock Price
23.76
Daily Change
1.18 5.23%
Monthly
-14.41%
Yearly
5.74%
Q1 Forecast
23.84

Celldex Therapeutics reported $-67.04M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Celldex Therapeutics USD -67.04M 10.44M Sep/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025